| |
JIA
|
Controls (TL)
|
P
|
Controls (PWV)
|
P
|
|---|
|
n = 24
|
n = 21
| |
n = 20
|
|---|
|
Age (years)
|
15,5 ± 6,3
|
11,4 ± 1,3
|
0, 005a
|
13,8 ± 5,9
|
0,184a
|
|
Gender - n (%)
|
|
Male
|
7 (26,1)
|
8 (40,9)
|
0,460b
|
6 (30)
|
0,458b
|
|
Female
|
17(73,9)
|
13 (59,1)
| |
14 (70)
| |
|
Ethnics - n (%)
|
|
Caucasian
|
19 (82,6)
|
17(81,8)
|
1, 000c
|
16 (80)
|
0,640c
|
|
Black
|
5 (17,4)
|
4 (18,2)
| |
4 (20)
| |
|
Weight (Kg)
|
50,1 ± 17,5
|
42,5 ± 10,2
|
0, 085a
|
46,8 ± 13,7
|
0,528a
|
|
Height (m)
|
1,52 ± 0,17
|
1,47 ± 0,09
|
0, 162a
|
1,44 ± 1,09
|
0,473a
|
|
BMI (KG/m2)
|
20,7 ± 3,7
|
19,6 ± 2,7
|
0, 247a
|
18,2 ± 4,9
|
0,372a
|
|
Duration disease (years) [P25 - P75]
|
9 [5–19]
| | | | |
|
Subtype – n (%)
|
|
Oligoarticular
|
15 (65,2)
| | | | |
|
Polyarticular
|
8 (34,8)
| | | | |
|
Medications – n(%)
|
|
Corticoids
|
8 (34,8)
| | | | |
|
NSAIDS
|
0(0,0)
| | | | |
|
Methotrexate
|
12 (52,2)
| | | | |
|
Leflunomide
|
10 (43,5)
| | | | |
|
Anti-TNF
|
7 (30,4)
| | | | |
|
Uveitis – n (%)
|
1 (4,3)
| | | | |
-
NSAIDS Nonsteroidal anti-inflammatory drugs, Anti-TNF Anti-tumour necrosis factor alpha agent
-
a T-student test; b Pearson test; c Fisher test
